Cancer Immunotherapy Meets Oncology

Um unseren Shop nutzen zu können, müssen Sie Javascript in Ihrem Browser aktivieren.

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

110,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 4-7 Werktage

Sie können kein Produkt in den Warenkorb legen, da Javascript und technisch notwendige Cookies aktiviert sein müssen.

Kategorien:

Der Artikel ist nicht in deutscher Sprache verfasst.
Die Sprache der Produktbeschreibung und Details kann in Englisch angegeben sein. Sollten Sie Verständnisprobleme haben, wenden Sie sich gerne an uns.

Beschreibung

This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing.
Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients.

Zusammenfassung

Provides a comprehensive update on the state of the art in cancer immunology

Describes the most promising therapeutic concepts, with coverage of combination therapies and personalized medicine

Discusses the role of biomarkers in guiding the clinical development of new treatment approaches

Inhaltsverzeichnis

Immunological and Regulatory Framework for Immuno-Oncology: From Basic Immunology to New Therapies for Patients.- How T cells single out tumor cells: 'and that has made all the difference'.- Tregs and Immune Inhibition.- Regulatory Landscape for Cancer Immunotherapy.- Immunoguiding.- Onco-Immunology Framework and Immunomodulatory Antibodies.- Immunotherapies: Peptide-based Vaccines and HPV Malignancies.- Dendritic cell based cancer vaccines.- RNA Vaccines and Personalized Medicine Approaches.-Antibody Therapy in Oncology.- Engineered Antibodies to Engage Immune Cells to the Tumor.- TCRs and TCR Therapy.- CAR Therapy.- Cancer Entities: Melanoma.- Prostate Cancer/Sipuleucel and RNA Vaccines.- Recent advances in the immunotherapy of renal cell cancer and other solid tumors.- Gastric Cancer.- NSCLC.- Breaking tolerance by allogeneic lymphocyte therapy.- Biomarkers: Exploring Immunogenic Cell Death for Patient Benefit.- Circulating Tumor Cells.- Genomics Meets Oncology.- Featured Chapters: Oncolytic Viruses.- Pharma View on Immunotherapy.- Final Remarks.

Details

Erscheinungsjahr:	2016
Fachbereich:	Andere Fachgebiete
Genre:	Medizin
Rubrik:	Wissenschaften
Medium:	Taschenbuch
Seiten:	260
Inhalt:	ix 248 S. 1 s/w Illustr. 18 farbige Illustr. 248 p. 19 illus. 18 illus. in color.
ISBN-13:	9783319381268
ISBN-10:	3319381261
Sprache:	Englisch
Ausstattung / Beilage:	Paperback
Einband:	Kartoniert / Broschiert
Redaktion:	Britten, Cedrik Michael Rammensee, Hans-Georg Diken, Mustafa Kreiter, Sebastian
Herausgeber:	Cedrik Michael Britten/Sebastian Kreiter/Mustafa Diken et al
Auflage:	Softcover reprint of the original 1st ed. 2014
Hersteller:	Springer International Publishing
Maße:	254 x 178 x 14 mm
Von/Mit:	Cedrik Michael Britten (u. a.)
Erscheinungsdatum:	23.08.2016
Gewicht:	0,555 kg